A threshold value of estimated glomerular filtration rate that predicts changes in serum 25-hydroxyvitamin D levels: 4th Korean National Health and Nutritional Examination Survey 2008

Nephrology Dialysis Transplantation

Volumn 27, Issue 6, 2012, Pages 2396-2403

  Oh, Yun Jung ^a   Kim, Myounghee ^b   Lee, Hajeong ^a   Lee, Jung Pyo ^c   Kim, Ho ^b   Kim, Sejoong ^d   Oh, Kook Hwan ^a   Joo, Kwon Wook ^a   Lim, Chun Soo ^a,c   Kim, Suhnggwon ^a   Kim, Yon Su ^a   Kim, Dong Ki ^a  

^a Seoul National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Boramae Hospital   (South Korea)

^d Seoul National University Bundang Hospital   (South Korea)

Author keywords

Epidemiology; Proteinuria; Renal function; Threshold; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D;

25 HYDROXYCOLECALCIFEROL BLOOD LEVEL; ADULT; CHRONIC KIDNEY DISEASE; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LOGISTIC REGRESSION ANALYSIS; MALE; MORTALITY; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; NUTRITION SURVEYS; PROGNOSIS; REPUBLIC OF KOREA; RISK FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84861863347     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr763     Document Type: Review

References (46)

1. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281
2. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 2009; 169: 626-632
3. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006; 81: 353-373
4. Gorham ED, Garland CF, Garland FC et al. Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol 2005; 97: 179-194
5. Merlino LA, Curtis J, Mikuls TR et al. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum 2004; 50: 72-77
6. Chiu KC, Chu A, Go VL et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825
7. Pittas AG, Dawson-Hughes B, Li T et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650-656
8. Mehrotra R, Kermah D, Budoff M et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1144-1151
9. Li YC, Qiao G, Uskokovic M et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol 2004; 89-90: 387-392
10. Migliori M, Giovannini L, Panichi V et al. Treatment with 1,25-dihydroxyvitamin D3 preserves glomerular slit diaphragm-associated protein expression in experimental glomerulonephritis. Int J Immunopathol Pharmacol 2005; 18: 779-790
11. Melamed ML, Astor B, Michos ED et al. 25-Hydroxyvitamin D levels, race, and the progression of kidney disease. J Am Soc Nephrol 2009; 20: 2631-2639
12. Mehrotra R, Kermah DA, Salusky IB et al. Chronic kidney disease, hypovitaminosis D, and mortality in the United States. Kidney Int 2009; 76: 977-983
13. Santoro D, Gitto L, Ferraro A et al. Vitamin d status and mortality risk in patients with chronic kidney disease. Ren Fail 2011; 33: 184-191
14. Pilz S, Tomaschitz A, Friedl C et al. Vitamin D status and mortality in chronic kidney disease. Nephrol Dial Transplant 2011; 26: 3603-3609
15. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39 (2 Suppl. 1): S1-S266
16. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl 2009; S1-S130
17. Forrest KY, Stuhldreher WL. Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 2011; 31: 48-54
18. Lips P. Worldwide status of vitamin D nutrition. J Steroid Biochem Mol Biol 2010; 121: 297-300
19. Levin A, Bakris GL, Molitch M et al. Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 2007; 71: 31-38
20. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42 (4 Suppl. 3): S1-S201
21. Levey AS, Coresh J, Balk E et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003; 139: 137-147
22. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163
23. Hastie T, Tibshirani R. Exploring the nature of covariate effects in the proportional hazards model. Biometrics 1990; 46: 1005-1016
24. Burnham KP, Anderson DR. Model Selection and Multimodel Inference: A Practical Information-Theoretic Approach. 2nd edn. New York, NY: Springer Verlag, 2002, pp. 1-488
25. Gonzalez EA, Sachdeva A, Oliver DA et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510
26. Ishimura E, Nishizawa Y, Inaba M et al. Serum levels of 1,25-dihydroxyvitamin D, 24,25-dihydroxyvitamin D, and 25-hydroxyvitamin D in nondialyzed patients with chronic renal failure. Kidney Int 1999; 55: 1019-1027
27. Chonchol M, Scragg R. 25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey. Kidney Int 2007; 71: 134-139
28. Urena-Torres P, Metzger M, Haymann JP et al. Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis 2011; 58: 544-553
29. Christensen EI, Birn H. Megalin and cubilin: synergistic endocytic receptors in renal proximal tubule. Am J Physiol Renal Physiol 2001; 280: F562-F573
30. Takemoto F, Shinki T, Yokoyama K et al. Gene expression of vitamin D hydroxylase and megalin in the remnant kidney of nephrectomized rats. Kidney Int 2003; 64: 414-420
31. Krajisnik T, Bjorklund P, Marsell R et al. Fibroblast growth factor 23 regulates parathyroid hormone and 1 alpha-hydroxylase expression in cultured bovine parathyroid cells. J Endocrinol 2007; 195: 125-131
32. Goldstein DA, Oda Y, Kurokawa K et al. Blood levels of 25-hydroxyvitamin D in patients with nephrotic syndrome. Ann Intern Med 1977; 87: 664-667
33. Saha H. Calcium and vitamin D homeostasis in patients with heavy proteinuria. Clin Nephrol 1994; 41: 290-296
34. de Boer IH, Ioannou GN, Kestenbaum B et al. 25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 2007; 50: 69-77
35. Isakova T, Gutierrez OM, Patel NM et al. Vitamin D deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 2011; 21: 295-302
36. Alborzi P, Patel NA, Peterson C et al. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized doubleblind pilot trial. Hypertension 2008; 52: 249-255
37. Agarwal R, Acharya M, Tian J et al. Antiproteinuric effect of oral paricalcitol in chronic kidney disease. Kidney Int 2005; 68: 2823-2828
38. de Zeeuw D, Agarwal R, Amdahl M et al. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 2010; 376: 1543-1551
39. Kim MJ, Frankel AH, Donaldson M et al. Oral cholecalciferol decreases albuminuria and urinary TGF-beta1 in patients with type 2 diabetic nephropathy on established renin-angiotensin-aldosterone system inhibition. Kidney Int 2011; 80: 851-860
40. Zadshir A, Tareen N, Pan D et al. The prevalence of hypovitaminosis D among US adults: data from the NHANES III. Ethn Dis 2005; 15 (4 Suppl 5): S5-97-S5-101
41. Mithal A, Wahl DA, Bonjour JP et al. Global vitamin D status and determinants of hypovitaminosis D. Osteoporos Int 2009; 20: 1807-1820
42. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76: 1536-1538
43. Scragg R, Camargo CA Jr. Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol 2008; 168: 577-586; discussion 587-591
44. Prentice A. Vitamin D deficiency: a global perspective. Nutr Rev 2008; 66 (10 Suppl 2): S153-S164
45. Rule AD, Larson TS, Bergstralh EJ et al. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004; 141: 929-937
46. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349